measles and mumps vaccine
Trade name: M-M-Vax
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2017 (NCT03133923)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Mumps virusImmunity, active
Mumps virus immunity, active
- Measles virusImmunity, active
Measles virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- measles and mumps vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04506463 | Phase 2 | Dec 31, 2020 | Moebius Medical Ltd., Sun Pharmaceuticals |
| NCT03133923 | Phase 2 | May 1, 2017 | Chinese Academy of Medical Sciences, Government of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Government of China | Government | 1 | 0 | 1 | 2017 |
| Moebius Medical Ltd. | For profit | 1 | 0 | 1 | 2020 |
| Sun Pharmaceuticals | For profit | 1 | 1 | 1 | 2020 |
4 organizations
Page 1 / 1